AQST

AQST Other Income/Expenses (Net)

-$25.48MTTM · USD

Period ending:

AQST FY Other Income/Expenses (Net)USD
AQST FY Other Income/Expenses (Net)2016-12-31: -$8.76M2017-12-31: -$8.83M2018-12-31: -$12.44M2019-12-31: -$13.58M2020-12-31: -$12.89M2021-12-31: -$35.86M2022-12-31: -$12.34M2023-12-31: $7.48M2024-12-31: -$13.38M2025-12-31: -$14.13M$7.48M-$35.86M
2016-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AQST other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 10 observations from Dec 31, 2016 to Dec 31, 2025.

Aquestive Therapeutics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-14,133,721
-13,380,000
7,477,000
-12,344,000
-35,860,000
-12,890,000
-13,578,000
-12,442,000
-8,830,000
-8,755,000

Compare other income/expenses (net)

All AQST financial metrics · AQST stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.